3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
1
Neoplasms
1
Interventions
apixaban
5
Rivaroxaban
5
Dalteparin
4
Enoxaparin
3
edoxaban
2
abelacimab
2
Tinzaparin
2
MAA868
2
Heparin, Low-Molecular-Weight
2
Dabigatran
2
isoquercitrin
1
calcium heparin
1
betrixaban
1
bemiparin
1
Warfarin
1
Heparin
1
Gemcitabine
1
Fondaparinux
1
AVE 5026
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Venous Thromboembolism
×
AVE 5026
×
Clear all
NCT00694382
2013-01-23
SAVE-ONCO
Sanofi
Phase 3
Completed
3,212 enrolled